Year |
Citation |
Score |
2022 |
Patino-Guerrero A, Ponce Wong RD, Kodibagkar VD, Zhu W, Migrino RQ, Graudejus O, Nikkhah M. Development and Characterization of Isogenic Cardiac Organoids from Human-Induced Pluripotent Stem Cells Under Supplement Starvation Regimen. Acs Biomaterials Science & Engineering. PMID 36583992 DOI: 10.1021/acsbiomaterials.2c01290 |
0.339 |
|
2022 |
Son Y, Zhu W. Gene Therapy for Cardiomyocyte Renewal: Cell Cycle, a Potential Therapeutic Target. Molecular Diagnosis & Therapy. PMID 36512179 DOI: 10.1007/s40291-022-00625-y |
0.306 |
|
2022 |
Zhu W, Sun J, Bishop SP, Sadek H, Zhang J. Turning back the clock: A concise viewpoint of cardiomyocyte cell cycle activation for myocardial regeneration and repair. Journal of Molecular and Cellular Cardiology. 170: 15-21. PMID 35660800 DOI: 10.1016/j.yjmcc.2022.05.010 |
0.358 |
|
2022 |
Joshi J, Xu B, Rubart M, Chang Y, Bao X, Chaliki HP, Scott LR, Zhu W. Optogenetic Control of Engrafted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Live Mice: A Proof-of-Concept Study. Cells. 11. PMID 35326403 DOI: 10.3390/cells11060951 |
0.312 |
|
2021 |
Zhao M, Nakada Y, Wei Y, Bian W, Chu Y, Borovjagin AV, Xie M, Zhu W, Nguyen T, Zhou Y, Serpooshan V, Walcott GP, Zhang J. Cyclin D2 Overexpression Enhances the Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Myocardial Repair in a Swine Model of Myocardial Infarction. Circulation. PMID 33951921 DOI: 10.1161/CIRCULATIONAHA.120.049497 |
0.331 |
|
2020 |
Fan C, Oduk Y, Zhao M, Lou X, Tang Y, Pretorius D, Valarmathi MT, Walcott GP, Yang J, Menasche P, Krishnamurthy P, Zhu W, Zhang J. Myocardial protection by nanomaterials formulated with CHIR99021 and FGF1. Jci Insight. PMID 32453715 DOI: 10.1172/Jci.Insight.132796 |
0.401 |
|
2020 |
Fan C, Tang Y, Zhao M, Lou X, Pretorius D, Menasche P, Zhu W, Zhang J. CHIR99021 and fibroblast growth factor 1 enhance the regenerative potency of human cardiac muscle patch after myocardial infarction in mice. Journal of Molecular and Cellular Cardiology. PMID 32169551 DOI: 10.1016/J.Yjmcc.2020.03.003 |
0.431 |
|
2019 |
Joshi J, Rubart M, Zhu W. Optogenetics: Background, Methodological Advances and Potential Applications for Cardiovascular Research and Medicine. Frontiers in Bioengineering and Biotechnology. 7: 466. PMID 32064254 DOI: 10.3389/Fbioe.2019.00466 |
0.366 |
|
2019 |
Govindappa PK, Patil M, Garikipati VNS, Verma SK, Saheera S, Narasimhan G, Zhu W, Kishore R, Zhang J, Krishnamurthy P. Targeting exosome-associated human antigen R attenuates fibrosis and inflammation in diabetic heart. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 31907992 DOI: 10.1096/Fj.201901995R |
0.376 |
|
2019 |
Fan C, Fast VG, Tang Y, Zhao M, Turner JF, Krishnamurthy P, Rogers JM, Valarmathi MT, Yang J, Zhu W, Zhang J. Cardiomyocytes from CCND2-overexpressing human induced-pluripotent stem cells repopulate the myocardial scar in mice: A 6-month study. Journal of Molecular and Cellular Cardiology. PMID 31629738 DOI: 10.1016/J.Yjmcc.2019.09.011 |
0.427 |
|
2019 |
Zhao M, Tang Y, Ernst PJ, Kahn-Krell A, Fan C, Pretorius D, Zhu H, Lou X, Zhou L, Zhang J, Zhu W. Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity. Journal of Visualized Experiments : Jove. PMID 31355804 DOI: 10.3791/59452 |
0.395 |
|
2019 |
Lou X, Zhao M, Fan C, Fast VG, Valarmathi MT, Zhu W, Zhang J. N-cadherin Overexpression Enhances the Reparative Potency of Human iPSC-Derived Cardiac Myocytes in Infarcted Mouse Hearts. Cardiovascular Research. PMID 31350544 DOI: 10.1093/Cvr/Cvz179 |
0.48 |
|
2019 |
Berry JL, Zhu W, Tang YL, Krishnamurthy P, Ge Y, Cooke JP, Chen Y, Garry DJ, Yang HT, Rajasekaran NS, Koch WJ, Li S, Domae K, Qin G, Cheng K, et al. Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure. Circulation Research. 124: 161-169. PMID 30605412 DOI: 10.1161/Circresaha.118.314216 |
0.361 |
|
2018 |
Zhu W, Reuter S, Field LJ. Targeted expression of cyclin D2 ameliorates late stage anthracycline cardiotoxicity. Cardiovascular Research. PMID 30423020 DOI: 10.1093/Cvr/Cvy273 |
0.59 |
|
2018 |
Wang J, Shen T, Zhu W, Dou L, Gu H, Zhang L, Yang Z, Chen H, Zhou Q, Sanchez ER, Field L, Mayo LD, Xie Z, Xiao D, Lin X, et al. Protein phosphatase 5 and the tumor suppressor P53 down-regulate each other's activities in mice. The Journal of Biological Chemistry. PMID 30262665 DOI: 10.1074/Jbc.Ra118.004256 |
0.624 |
|
2018 |
Zhao M, Fan C, Ernst PJ, Tang Y, Zhu H, Mattapally S, Oduk Y, Borovjagin AV, Zhou L, Zhang J, Zhu W. Y-27632 Preconditioning Enhances Transplantation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Myocardial Infarction Mice. Cardiovascular Research. PMID 30107391 DOI: 10.1093/Cvr/Cvy207 |
0.41 |
|
2018 |
Zhu W, Zhang E, Zhao M, Chong Z, Fan C, Tang Y, Hunter JD, Borovjagin AV, Walcott GP, Chen JY, Qin G, Zhang J. Regenerative Potential of Neonatal Porcine Hearts. Circulation. PMID 30030418 DOI: 10.1161/Circulationaha.118.034886 |
0.439 |
|
2018 |
Zhang J, Zhu W, Radisic M, Vunjak-Novakovic G. Can We Engineer a Human Cardiac Patch for Therapy? Circulation Research. 123: 244-265. PMID 29976691 DOI: 10.1161/Circresaha.118.311213 |
0.335 |
|
2018 |
Mattapally S, Zhu W, Fast VG, Gao L, Worley C, Kannappan R, Borovjagin AV, Zhang J. Spheroids of cardiomyocytes derived from human induced-pluripotent stem cells improve recovery from myocardial injury in mice. American Journal of Physiology. Heart and Circulatory Physiology. PMID 29631371 DOI: 10.1152/Ajpheart.00688.2017 |
0.453 |
|
2017 |
Gao L, Gregorich ZR, Zhu W, Mattapally S, Oduk Y, Lou X, Kannappan R, Borovjagin AV, Walcott GP, Pollard AE, Fast VG, Hu X, Lloyd SG, Ge Y, Zhang J. Large Cardiac-Muscle Patches Engineered from Human Induced-Pluripotent Stem-Cell-Derived Cardiac Cells Improve Recovery from Myocardial Infarction in Swine. Circulation. PMID 29233823 DOI: 10.1161/Circulationaha.117.030785 |
0.446 |
|
2017 |
Oduk Y, Zhu W, Kannappan R, Zhao M, Borovjagin AV, Oparil S, Zhang J. VEGF Nanoparticles Repair Heart after Myocardial Infarction. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00471.2017. PMID 29101176 DOI: 10.1152/Ajpheart.00471.2017 |
0.351 |
|
2017 |
Toischer K, Zhu W, Hünlich M, Mohamed BA, Khadjeh S, Reuter SP, Schäfer K, Ramanujam D, Engelhardt S, Field LJ, Hasenfuss G. Cardiomyocyte proliferation prevents failure in pressure overload but not volume overload. The Journal of Clinical Investigation. PMID 29083322 DOI: 10.1172/Jci81870 |
0.656 |
|
2017 |
Zhu W, Zhao M, Mattapally S, Chen S, Zhang J. CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle. Circulation Research. PMID 29018036 DOI: 10.1161/Circresaha.117.311504 |
0.448 |
|
2017 |
Yanamandala M, Zhu W, Garry DJ, Kamp TJ, Hare JM, Jun HW, Yoon YS, Bursac N, Prabhu SD, Dorn GW, Bolli R, Kitsis RN, Zhang J. Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering. Journal of the American College of Cardiology. 70: 766-775. PMID 28774384 DOI: 10.1016/J.Jacc.2017.06.012 |
0.419 |
|
2017 |
Zhu W, Zhang J. Meeting Report for the 2017 National Institutes of Health National Heart, Lung, and Blood Institute Progenitor Cell Biology Consortium: Cardiovascular Bioengineering Workshop and Symposium. Circulation Research. 120: 1709-1712. PMID 28546353 DOI: 10.1161/Circresaha.117.311086 |
0.33 |
|
2017 |
Zhu W, Gao L, Zhang J. Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair. Journal of Visualized Experiments : Jove. PMID 28190029 DOI: 10.3791/55142 |
0.384 |
|
2016 |
Gao L, Cui W, Zhang P, Jang A, Zhu W, Zhang J. 31P NMR 2D Mapping of Creatine Kinase Forward Flux Rate in Hearts with Postinfarction Left Ventricular Remodeling in Response to Cell Therapy. Plos One. 11: e0162149. PMID 27606901 DOI: 10.1371/Journal.Pone.0162149 |
0.424 |
|
2015 |
Zhang W, Qu X, Chen B, Snyder M, Wang M, Li B, Tang Y, Chen H, Zhu W, Zhan L, Yin N, Li D, Li X, Liu Y, Zhang JJ, et al. Critical Roles of STAT3 in β-Adrenergic Functions in the Heart. Circulation. PMID 26628621 DOI: 10.1161/Circulationaha.115.017472 |
0.425 |
|
2014 |
Zhu W, Zhang W, Shou W, Field LJ. P53 inhibition exacerbates late-stage anthracycline cardiotoxicity. Cardiovascular Research. 103: 81-9. PMID 24812279 DOI: 10.1093/Cvr/Cvu118 |
0.6 |
|
2013 |
Chen H, Zhang W, Sun X, Yoshimoto M, Chen Z, Zhu W, Liu J, Shen Y, Yong W, Li D, Zhang J, Lin Y, Li B, VanDusen NJ, Snider P, et al. Fkbp1a controls ventricular myocardium trabeculation and compaction by regulating endocardial Notch1 activity. Development (Cambridge, England). 140: 1946-57. PMID 23571217 DOI: 10.1242/Dev.089920 |
0.663 |
|
2013 |
Zhu W, Soonpaa MH, Zhang W, Shou W, Payne M, Field LJ. Abstract 5602: Cyclin D2- mediated cardiomyocyte cell cycle activity reverses doxorubicin-induced cardiotoxicity. Cancer Research. 73: 5602-5602. DOI: 10.1158/1538-7445.Am2013-5602 |
0.646 |
|
2012 |
Choi EK, Chang PC, Lee YS, Lin SF, Zhu W, Maruyama M, Fishbein MC, Chen Z, Rubart-von der Lohe M, Field LJ, Chen PS. Triggered firing and atrial fibrillation in transgenic mice with selective atrial fibrosis induced by overexpression of TGF-β1. Circulation Journal : Official Journal of the Japanese Circulation Society. 76: 1354-62. PMID 22447020 DOI: 10.1253/Circj.Cj-11-1301 |
0.586 |
|
2012 |
Zaruba MM, Zhu W, Soonpaa MH, Reuter S, Franz WM, Field LJ. Granulocyte colony-stimulating factor treatment plus dipeptidylpeptidase-IV inhibition augments myocardial regeneration in mice expressing cyclin D2 in adult cardiomyocytes. European Heart Journal. 33: 129-37. PMID 21849352 DOI: 10.1093/Eurheartj/Ehr302 |
0.644 |
|
2012 |
Zhu W, Reuter S, Zhang W, Wagner GR, Payne RM, Caldwell RL, Shou W, Field LJ. Abstract 2500: The pivotal role of p53 in doxorubicin-induced acute versus chronic cardiotoxicity Cancer Research. 72: 2500-2500. DOI: 10.1158/1538-7445.Am2012-2500 |
0.65 |
|
2011 |
Zhang W, Chen H, Wang Y, Yong W, Zhu W, Liu Y, Wagner GR, Payne RM, Field LJ, Xin H, Cai CL, Shou W. Tbx20 transcription factor is a downstream mediator for bone morphogenetic protein-10 in regulating cardiac ventricular wall development and function. The Journal of Biological Chemistry. 286: 36820-9. PMID 21890625 DOI: 10.1074/Jbc.M111.279679 |
0.656 |
|
2011 |
Li D, Liu Y, Maruyama M, Zhu W, Chen H, Zhang W, Reuter S, Lin SF, Haneline LS, Field LJ, Chen PS, Shou W. Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy. Human Molecular Genetics. 20: 4582-96. PMID 21880664 DOI: 10.1093/Hmg/Ddr392 |
0.663 |
|
2011 |
Maruyama M, Li BY, Chen H, Xu X, Song LS, Guatimosim S, Zhu W, Yong W, Zhang W, Bu G, Lin SF, Fishbein MC, Lederer WJ, Schild JH, Field LJ, et al. FKBP12 is a critical regulator of the heart rhythm and the cardiac voltage-gated sodium current in mice. Circulation Research. 108: 1042-52. PMID 21372286 DOI: 10.1161/Circresaha.110.237867 |
0.653 |
|
2011 |
Li D, Hallett MA, Zhu W, Rubart M, Liu Y, Yang Z, Chen H, Haneline LS, Chan RJ, Schwartz RJ, Field LJ, Atkinson SJ, Shou W. Dishevelled-associated activator of morphogenesis 1 (Daam1) is required for heart morphogenesis. Development (Cambridge, England). 138: 303-15. PMID 21177343 DOI: 10.1242/Dev.055566 |
0.653 |
|
2011 |
Toischer K, Rokita AG, Unsöld B, Sossalla S, Becker A, Seidler T, Grebe C, Preuß L, Gupta SN, Schmidt K, Lehnart SE, Schäfer K, Maier LS, Hasenfuss G, Zhu W, et al. Response to letter regarding article, "differential Cardiac Remodeling in Preload Versus Afterload" Circulation. 123: e421. DOI: 10.1161/Circulationaha.110.017566 |
0.6 |
|
2010 |
Toischer K, Rokita AG, Unsöld B, Zhu W, Kararigas G, Sossalla S, Reuter SP, Becker A, Teucher N, Seidler T, Grebe C, Preuss L, Gupta SN, Schmidt K, Lehnart SE, et al. Differential cardiac remodeling in preload versus afterload. Circulation. 122: 993-1003. PMID 20733099 DOI: 10.1161/Circulationaha.110.943431 |
0.607 |
|
2009 |
Tang YL, Zhu W, Cheng M, Chen L, Zhang J, Sun T, Kishore R, Phillips MI, Losordo DW, Qin G. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circulation Research. 104: 1209-16. PMID 19407239 DOI: 10.1161/Circresaha.109.197723 |
0.486 |
|
2009 |
Zhu W, Hassink RJ, Rubart M, Field LJ. Cell-cycle-based strategies to drive myocardial repair. Pediatric Cardiology. 30: 710-5. PMID 19340478 DOI: 10.1007/S00246-009-9408-3 |
0.66 |
|
2009 |
Zhu W, Soonpaa MH, Chen H, Shen W, Payne RM, Liechty EA, Caldwell RL, Shou W, Field LJ. Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway. Circulation. 119: 99-106. PMID 19103993 DOI: 10.1161/Circulationaha.108.799700 |
0.596 |
|
2009 |
Chen Q, Chen H, Zheng D, Kuang C, Fang H, Zou B, Zhu W, Bu G, Jin T, Wang Z, Zhang X, Chen J, Field LJ, Rubart M, Shou W, et al. Smad7 is required for the development and function of the heart. The Journal of Biological Chemistry. 284: 292-300. PMID 18952608 DOI: 10.1074/Jbc.M807233200 |
0.643 |
|
2008 |
Zhu W, Shou W, Payne RM, Caldwell R, Field LJ. A mouse model for juvenile doxorubicin-induced cardiac dysfunction. Pediatric Research. 64: 488-94. PMID 18614963 DOI: 10.1203/Pdr.0B013E318184D732 |
0.675 |
|
2008 |
Xu X, Sarikas A, Dias-Santagata DC, Dolios G, Lafontant PJ, Tsai SC, Zhu W, Nakajima H, Nakajima HO, Field LJ, Wang R, Pan ZQ. The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation. Molecular Cell. 30: 403-14. PMID 18498745 DOI: 10.1016/J.Molcel.2008.03.009 |
0.567 |
|
2008 |
Shen WH, Chen Z, Shi S, Chen H, Zhu W, Penner A, Bu G, Li W, Boyle DW, Rubart M, Field LJ, Abraham R, Liechty EA, Shou W. Cardiac restricted overexpression of kinase-dead mammalian target of rapamycin (mTOR) mutant impairs the mTOR-mediated signaling and cardiac function. The Journal of Biological Chemistry. 283: 13842-9. PMID 18326485 DOI: 10.1074/Jbc.M801510200 |
0.677 |
|
2007 |
Dowell JD, Tsai SC, Dias-Santagata DC, Nakajima H, Wang Z, Zhu W, Field LJ. Expression of a mutant p193/CUL7 molecule confers resistance to MG132- and etoposide-induced apoptosis independent of p53 or Parc binding. Biochimica Et Biophysica Acta. 1773: 358-66. PMID 17229476 DOI: 10.1016/J.Bbamcr.2006.11.020 |
0.691 |
|
2006 |
Chen H, Yong W, Ren S, Shen W, He Y, Cox KA, Zhu W, Li W, Soonpaa M, Payne RM, Franco D, Field LJ, Rosen V, Wang Y, Shou W. Overexpression of bone morphogenetic protein 10 in myocardium disrupts cardiac postnatal hypertrophic growth. The Journal of Biological Chemistry. 281: 27481-91. PMID 16798733 DOI: 10.1074/Jbc.M604818200 |
0.675 |
|
2006 |
Zhu W, Field LJ, Wells HB. 16 Myocardial Expression of Mutant P53 Protects Against Doxorubicin-Induced Cardiomyocyte Apoptosis and Preserves Heart Function. Pediatric Research. 60: 493-493. DOI: 10.1203/00006450-200610000-00038 |
0.674 |
|
Show low-probability matches. |